A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PFE / pomegranate fruit extract

[Related PubMed/MEDLINE]
Total Number of Papers: 25
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PFE  (>> Co-occurring Abbreviation)
Long Form:   pomegranate fruit extract
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 Inhibition of cartilage degradation and suppression of PGE2 and MMPs expression by pomegranate fruit extract in a model of posttraumatic osteoarthritis. IL, MAPK, MMP, NF, OA, PG
2017 Pomegranate Consumption and Blood Pressure: A Review. BP, PJ, PP, PSO
2016 Pomegranate protects against arsenic-induced p53-dependent ROS-mediated inflammation and apoptosis in liver cells. NF-kappaB, Nrf2, ROS
2015 Anti-Glycation Effects of Pomegranate (Punica granatum L.) Fruit Extract and Its Components in Vivo and in Vitro. AGEs
2015 Protective effect of pomegranate flower extract against gentamicin-induced renal toxicity in male rats. BUN, Cr, GM
2015 The effect of pomegranate fruit extract on testosterone-induced BPH in rats. BPH
2014 Effect of pomegranate flower extract on cisplatin-induced nephrotoxicity in rats. CP, MDA
2014 Pomegranate Flower Extract does not Prevent Cisplatin-Induced Nephrotoxicity in Female Rats. ---
2013 Ellagic acid improves hepatic steatosis and serum lipid composition through reduction of serum resistin levels and transcriptional activation of hepatic ppara in obese, diabetic KK-A(y) mice. EA
10  2013 Pomegranate reverses methotrexate-induced oxidative stress and apoptosis in hepatocytes by modulating Nrf2-NF-kappaB pathways. MTX
11  2012 Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes. EA
12  2012 Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model. PCa
13  2012 Pomegranate fruit extract inhibits UVB-induced inflammation and proliferation by modulating NF-kappaB and MAPK signaling pathways in mouse skin. UVB
14  2011 Synergistic growth inhibition of mouse skin tumors by pomegranate fruit extract and diallyl sulfide: evidence for inhibition of activated MAPKs/NF-kappaB and reduced cell proliferation. DAS
15  2010 Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. 8-oxodG, CPDs, NF-kappaB, ODC
16  2007 Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis. eNOS
17  2007 Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. NTCU
18  2007 Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. CDK, NHBE
19  2007 The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. eNOS, NO, PJ, TSP
20  2006 Photochemopreventive effect of pomegranate fruit extract on UVA-mediated activation of cellular pathways in normal human epidermal keratinocytes. MAPKs, NHEK, STAT3
21  2006 Prostate cancer prevention through pomegranate fruit. PSA
22  2005 Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. ODC, TPA
23  2005 Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. MAPK, NF-kappaB, NHEK, UV
24  2005 Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. CDK
25  2005 Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro. IkappaBalpha, IL, MAPKs, MMPs, NF-kappaB, OA